Co-Diagnostics Inc says its CoSara Diagnostics Pvt Ltd joint venture with Synbiotics Ltd in India garnering media attention for its actions to combat coronavirus surge
Co-Diagnostics says its CoSara joint venture in India garnering media attention as it combats coronavirus surge In particular, the Indian media have noted the extraordinary efforts of a CoSara team of six women who have increased capacity from roughly 8,000 coronavirus PCR tests per day a year ago to around 40,000 per day now In April 2020, CoSara, a joint venture with Synbiotics, became the first company headquartered in India to get a license to manufacture coronavirus test kits Co-Diagnostics Inc (NASDAQ:CODX) has noted that its Indian manufacturing facility, CoSara Diagnost...